21907020/National Natural Science Foundation of China[Grants and Funding] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Year	Number of Results
2022	1
2023	1
2025	1

Page 1

Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition.

Li M, Wang D, Li Q, Luo F, Zhong T, Wu H, Xiong L, Yuan M, Su M, Fan Y. Li M, et al. Int J Mol Sci. 2023 Apr 6;24(7):6851. doi: 10.3390/ijms24076851. Int J Mol Sci. 2023. PMID: 37047827 Free PMC article.

Antiproliferative Activity of a New Quinazolin-4(3H)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer.

Lee JY, Yang H, Kim D, Kyaw KZ, Hu R, Fan Y, Lee SK. Lee JY, et al. Pharmaceuticals (Basel). 2022 Jun 2;15(6):698. doi: 10.3390/ph15060698. Pharmaceuticals (Basel). 2022. PMID: 35745617 Free PMC article.

Discovery of FLF-15 as a novel selective inhibitor of ADAM17 to prevent hepatocellular carcinoma metastasis.

Li Q, Wang DP, Zhong T, Ling-Hu AL, Chen JL, Luo F, Zhang F, Su MZ, Yang Y, Fan YH. Li Q, et al. Mol Divers. 2025 Jun 26. doi: 10.1007/s11030-025-11275-7. Online ahead of print. Mol Divers. 2025. PMID: 40569520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year